Neuronetics (STIM) Restructuring Costs (2025 - 2026)
Neuronetics (STIM) posted quarterly Restructuring Costs of $8.5 million for Q1 2026, little changed year-over-year from $8.5 million in Q1 2025, and little changed quarter-over-quarter from $8.5 million in Q1 2025.
Neuronetics (STIM) Restructuring Costs (2025 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Restructuring Costs for 2 consecutive years, with $8.5 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Neuronetics | 225.24 Mn | 205.80 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.82 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Mar 31, 2025 | 8.47 Mn |